A Voxel Based Morphometric Analysis of Longitudinal Cortical Gray Matter Changes in Progranulin Mutation Carriers At-Risk for Frontotemporal Dementia: Preliminary Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose One of the most common genetic causes of frontotemporal dementia (FTD) is mutation in the progranulin(PGRN) gene. The aim of this study is to assess the early effects of the PGRN mutations on brain volumes by longitudinal voxel based morphometric(VBM) evaluation in asymptomatic mutation carriers. Methods We recruited 17 asymptomatic members of families with FTD caused by PGRN mutations; 7 mutation carriers (51.0±11.6 yr)and 10 non-carriers (55.2±6.0 yr, p=0.404). The MRI follow-up intervals of carriers and non-carriers were 788.6±103.8 and 922.0±225.1 days(p=0.124) respectively. We performed cross-sectional and longitudinal VBM analysis on both groups. Results At baseline, the carriers had lower white matter (WM) volumes in left frontal regions (p<0.001, uncorrected), but had no gray matter(GM) volume reduction. The carrier’s global GM (p=0.924) and WM volume (p=0.364) reduction rate were not different from the noncarrier’s. However, statistical parametric mapping T-maps showed differentially increased GM volume reductions in the bilateral parietal areasof carriers (p<0.001, uncorrected). Conclusions The findings from this study to examine WM and GM cross-sectional and longitudinal changes in PGRN mutation carrierssuggest that WM atrophic changes could precede both GM changes and symptom onset in FTD. Asymptomatic PGRN mutation carriershave measurably higher rates of regional GM atrophy than non-carriers even in the pre-dementia stages.
Abstract
Background and Purpose One of the most common genetic causes of frontotemporal dementia (FTD) is mutation in the progranulin(PGRN) gene. The aim of this study is to assess the early effects of the PGRN mutations on brain volumes by longitudinal voxel based morphometric(VBM) evaluation in asymptomatic mutation carriers. Methods We recruited 17 asymptomatic members of families with FTD caused by PGRN mutations; 7 mutation carriers (51.0±11.6 yr)and 10 non-carriers (55.2±6.0 yr, p=0.404). The MRI follow-up intervals of carriers and non-carriers were 788.6±103.8 and 922.0±225.1 days(p=0.124) respectively. We performed cross-sectional and longitudinal VBM analysis on both groups. Results At baseline, the carriers had lower white matter (WM) volumes in left frontal regions (p<0.001, uncorrected), but had no gray matter(GM) volume reduction. The carrier’s global GM (p=0.924) and WM volume (p=0.364) reduction rate were not different from the noncarrier’s. However, statistical parametric mapping T-maps showed differentially increased GM volume reductions in the bilateral parietal areasof carriers (p<0.001, uncorrected). Conclusions The findings from this study to examine WM and GM cross-sectional and longitudinal changes in PGRN mutation carrierssuggest that WM atrophic changes could precede both GM changes and symptom onset in FTD. Asymptomatic PGRN mutation carriershave measurably higher rates of regional GM atrophy than non-carriers even in the pre-dementia stages.
참고문헌 (14)
- Chow TW, "Inheritance of frontotemporal dementia", Arch Neurol, 56, pp.817~822 (1999)
- Rizzu P, "High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands", Am J Hum Genet, 64, pp.414~421 (1999)
- Rademakers R, "The role of tau (MAPT)in frontotemporal dementia and related tauopathies", Hum Mutat, 24, pp.277~295 (2004)
- Baker M, "Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17", Nature, 442, pp.916~919 (2006)
- Cruts M, "Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21", Nature, 442, pp.920~924 (2006)
- Pickering-Brown SM, "Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations", Brain, 131(Pt 3), pp.721~731 (2008)
- Whitwell JL, "Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations", Arch Neurol, 64, pp.371~376 (2007)
- Huey ED, "Characteristics of frontotemporal dementia patients with a Progranulin mutation", Ann Neurol, 60, pp.374~380 (2006)
- Rohrer JD, "Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene", Arch Neurol, 65, pp.506~513 (2008)
- Le Ber I, "Phenotype variability in progranulin mutation carriers:a clinical, neuropsychological, imaging and genetic study", Brain, 131(Pt 3), pp.732~746 (2008)
- Beck J, "A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series", Brain, 131(Pt 3), pp.706~720 (2008)
- Borroni B, "Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers", Rejuvenation Res, 11, pp.585~595 (2008)
- Cruchaga C, "Cortical atrophy and language network reorganization associated with a novel progranulin mutation", Cereb Cortex, 19, pp.1751~1760 (2009)
- Gass J, "Progranulin: an emerging target for FTLD therapies", Brain Res, 1462, pp.118~128 (2012)